Mission
NEUROSERVICE is a private CRO (Contract Research Organization) focused exclusively on in vitro electrophysiological recordings of the CNS.
Our mission is to support our customers in the lead selection and optimization phases of their CNS & PAIN R&D programs, thanks to our portfolio of reliable and reproducible electrophysiological assays, supported by a highly experienced team in neurophysiology, neuropharmacology and neurotoxicology.
Our state of the art facilities enable NEUROSERVICE to meet each customer's needs, from standardized to individually customized assays.
Assets
NEUROSERVICE has unparalleled expertise in hands-on electrophysiological assays performed with the Multi-electrode array (MEA) and Patch-clamp techniques. Scalable processes, ready channels of communication and attention to detail ensure the delivery of high quality data with a global reach.
-
NEUROSERVICE will exhibit and participate in the BIO International Convention in Boston, June 18-21, 2012
On 15/05/2012
We would be pleased to meet you during the BIO Convention and present you in more details the expertise and capabilities of NEUROSERVICE. Visit us booth #3076 !
+ read more -
NEW: North America Scientific Representative
On 12/04/2012
NEUROSERVICE is now collaborating with Jeffrey Sprouse, Ph.D, who will serve as North America Scientific Representative.
+ read more -
Thanks for visiting us at SOT ToxExpo, March 11-15, 2012 in San Francisco
On 22/03/2012
Thanks for visiting us and for your interest in our in vitro assays in acute brain slices focusing Safety & Toxicology!
+ read more
-
NEUROSERVICE attended the 7th Annual CHDI Foundation meeting, Feb 27- March 1, 2012 in Palm Springs, CA
On 06/03/2012
NEUROSERVICE attended the 7th Annual CHDI Foundation meeting.
+ read more -
Select your compounds devoid of any undesired CNS side effects
On 16/01/2012
NEUROSERVICE validated a range of in vitro electrophysiological based assays able to predict major proconvulsant liabilities.
+ read more -
Your compound targets the M1 mACh Receptor ? Discover the new assay of NEUROSERVICE
On 16/09/2011
NEUROSERVICE has validated a new in vitro electrophysiological test to evaluate the pharmacological activity/profile of your compound at M1 receptors.
+ read more -
New functional assay on GABA-A receptors in acute slices
On 14/01/2011
NEUROSERVICE has validated a new test to investigate any compound effects on the GABA-A receptors and inhibitory synaptic transmission.
+ read more -
Document direct effect of compounds on NMDA receptors !
On 21/10/2010
For research focused on neurodegenerative diseases, ischemia, schizophrenia, NEUROSERVICE has developed a new functional assay to screen compounds on NMDA receptors.
+ read more